BioCentury
ARTICLE | Clinical News

Levobupivacaine data

January 22, 1996 8:00 AM UTC

Chiroscience announced results from the first of two Phase III U.K. trials. In 97 patients undergoing lower limb surgery, the product displayed the same anesthetic properties as racemic bupivacaine.

A previous study showed that levobupivacaine had one-third of the cardiotoxicity of racemic bupivacaine, the company said. ...